share_log
Breakings ·  Dec 18 21:01
Krystal Biotech Inc - Reports 27% Orr and 73% Dcr in Nsclc Trial
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment